New targeted drug enters human trials for advanced cancers
Disease control
Recruiting now
This early-stage study is testing a new experimental drug called ETX-636 in people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The trial will first check the safety and side effects of the drug given alone, and then test it combined with anot…
Phase: PHASE1, PHASE2 • Sponsor: Ensem Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC